4 research departments
750 employees
45 nationalities
55 research teams
16 ERC laureates
260 publications per year
24000 m² lab area

Support us through

Fondation universite de Strasbourg

Communication Service

Tél. +33(0) 3 88 65 35 47

Quick Links

Science & society

Key figures 2017

12 prizes and distinctions
3 public events
26 major scientific news

Scientific news

Production of unstable proteins through the formation of stable core complexes

To assemble stable functional complexes, various partners (multi-domains proteins (X-Y-Z) connected by unstructured linkers (blue lines) allowing high inter domain flexibility (double arrow), single domain proteins (A, B), nucleic acids (DNA or RNA), small molecules (yellow disks)) are necessary.

Production of unstable proteins through the formation of stable core complexes.

Levy N(1), Eiler S(1), Pradeau-Aubreton K(1), Maillot B(1), Stricher F(1), Ruff M(1).

Nat Commun March 17, 2016

March 29, 2016

The team of Marc Ruff works on chromatin stability and DNA mobility. Scientists have recently developed a methodology that enables the production of stable complexes for their structural and functional studies. These results were published in the journal Nature Communications on March 17, 2016.


The main focus of the team of Marc Ruff is to understand the molecular processes performed by nucleoprotein complexes involving the human immunodeficiency virus (HIV) integrase. The purpose is to provide four dimensional views of these complexes during the replication cycle of HIV.


Towards the establishment of a methodology for stable complex production

Recent advances in biology have shown that most cellular functions are performed by transient multi-protein complexes. Protein purification is a series of processes intended to isolate one or a few proteins from a complex mixture, usually cells or tissues. Protein purification is vital in basic research for the characterization of the function, structure and interactions of the relevant protein. It is also essential in applied research and industry to prepare products and reagents.


The purification of proteins that participate in large transient complexes is impeded by low amounts, heterogeneity, instability and poor solubility. To circumvent these difficulties researchers have set up a methodology that enables the production of stable complexes for structural and functional studies. This procedure is benchmarked and applied to two challenging protein families: the human steroid nuclear receptors and the HIV-1 pre-integration complex.


Therapeutic application of this technology is also considered by the research team. Indeed, the multi-protein complexes obtained are used for the discovery of a new family of medicine: conformational inhibitors. These molecules act by blocking the protein in a given form and will allow the inhibition of the viral infection in the case of HIV.


Imprimer Envoyer

Université de Strasbourg

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr